Overview of methodology for lung cancer evidence review and guideline development

Chest

Volumn 123, Issue 1 SUPPL., 2003, Pages 3S-6S

  McCrory, Douglas C ^a,e   Colice, Gene L ^b   Lewis, Sandra Zelman ^c   Alberts, W Michael ^d   Parker, Sydney ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c American College of Chest Physicians   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

Advisory committees; Evidence based medicine; Lung neoplasms; Practice guidelines

Indexed keywords

ACCURACY; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; EARLY DIAGNOSIS; HUMAN; LUNG CANCER; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 0037245905     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.1_suppl.3S     Document Type: Article

References (2)

1. AGREE Collaborative Group. Appraisal of guidelines for research & evaluation (AGREE) instrument: second draft; August 2000. Available at: http://www.agreecollaboration.org. Accessed December 16, 2002
2. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med 2001; 20(suppl):21-35